functions

A collection of 499 selected human endogenous metabolites for high throughput and high content screening.

A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;

A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 614 gut microbial metabolites which can be used for HTS and HCS;

A unique collection of 514 flavonoids can be used for high throughput and high content screening；

A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 604 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;

A unique collection of 759 cytoskeleton-related compounds, can be used for HTS and HCS；

A unique collection of 140 calcium channel blockers and agonists for high throughput and high content screening;

A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;

A unique collection of 184 TGF-beta Smad signaling targeted compounds for high throughput and high content screening;

A unique collection of 580 compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis.

A unique collection of 509 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 152 potassium channel blockers and agonists for high throughput and high content screening;

A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1336 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies；

76 exosome-related compounds that can be used for high-throughput and high-content screening.